Literature DB >> 23707641

Structure of the psychotic disorders classification in DSM-5.

Stephan Heckers1, Deanna M Barch, Juan Bustillo, Wolfgang Gaebel, Raquel Gur, Dolores Malaspina, Michael J Owen, Susan Schultz, Rajiv Tandon, Ming Tsuang, Jim Van Os, William Carpenter.   

Abstract

Schizophrenia spectrum disorders attract great interest among clinicians, researchers, and the lay public. While the diagnostic features of schizophrenia have remained unchanged for more than 100 years, the mechanism of illness has remained elusive. There is increasing evidence that the categorical diagnosis of schizophrenia and other psychotic disorders contributes to this lack of progress. The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) continues the categorical classification of psychiatric disorders since the research needed to establish a new nosology of equal or greater validity is lacking. However, even within a categorical system, the DSM-5 aims to capture the underlying dimensional structure of psychosis. The domains of psychopathology that define psychotic disorders are presented not simply as features of schizophrenia. The level, the number, and the duration of psychotic signs and symptoms are used to demarcate psychotic disorders from each other. Finally, the categorical assessment is complemented with a dimensional assessment of psychosis that allows for more specific and individualized assessment of patients. The structure of psychosis as outlined in the DSM-5 may serve as a stepping-stone towards a more valid classification system, as we await new data to redefine psychotic disorders.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DSM; Diagnosis; Nosology; Psychotic disorders; Schizophrenia

Mesh:

Year:  2013        PMID: 23707641     DOI: 10.1016/j.schres.2013.04.039

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  45 in total

Review 1.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

2.  Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia.

Authors:  Taina Mattila; Maarten Koeter; Tamar Wohlfarth; Jitschak Storosum; Wim van den Brink; Lieuwe de Haan; Eske Derks; Hubertus Leufkens; Damiaan Denys
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

Review 3.  Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.

Authors:  Sabina Berretta; Stephan Heckers; Francine M Benes
Journal:  Schizophr Res       Date:  2014-11-11       Impact factor: 4.939

4.  Toward the early recognition of psychosis among Spanish-speaking adults on both sides of the U.S.-Mexico border.

Authors:  Rachel Nichole Casas; Edlin Gonzales; Eréndira Aldana-Aragón; María Del Carmen Lara-Muñoz; Alex Kopelowicz; Laura Andrews; Steven Regeser López
Journal:  Psychol Serv       Date:  2014-11

Review 5.  The Epidemiology and Associated Phenomenology of Formal Thought Disorder: A Systematic Review.

Authors:  Eric Roche; Lisa Creed; Donagh MacMahon; Daria Brennan; Mary Clarke
Journal:  Schizophr Bull       Date:  2014-09-01       Impact factor: 9.306

Review 6.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

Review 7.  The Clinical Features of Paranoia in the 20th Century and Their Representation in Diagnostic Criteria From DSM-III Through DSM-5.

Authors:  Kenneth S Kendler
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

8.  Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder.

Authors:  Brianne Brown; Larry Alphs; Ibrahim Turkoz; Yong Yue
Journal:  Psychopharmacol Bull       Date:  2017-08-01

Review 9.  Stem cell-based models and therapies: a key approach into schizophrenia treatment.

Authors:  Bagher Larijani; Peyvand Parhizkar Roudsari; Mahdieh Hadavandkhani; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Forough Azam Sayahpour; Fereshteh Mohamadi-Jahani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2021-01-02       Impact factor: 1.522

10.  [Schizophrenia and other psychotic disorders in DSM-5: summary of the changes compared to DSM-IV].

Authors:  M Paulzen; F Schneider
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.